Recurrent PCI at ten years after treatment with biodegradable vs. permanent Polymer DES: The ISAR-TEST 4 Trial
The ISAR-TEST 4 trial demonstrated that after 10 years of follow-up following PCI, biodegradable polymer sirolimus-eluting stents were associated with a lower risk of total TLR compared with early-generation durable polymer sirolimus-eluting stents, while no significant difference was observed compared with durable polymer everolimus-eluting stents, according to a study presented by Dr. Karsten Hug, Deutsches Herzzentrum München, Germany, in the Hotline/Late-Breaking Trials session at EuroPCR 2026.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
